Financial statements Labmind
Balance sheet data of LABMIND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|---|---|---|
| Total assets | 567 884,54 | 175 649,85 | 70 014,43 | 1 069 701,15 | 2 063 789,52 | 810 276,64 | 418 701,67 | 191 578,23 |
| A. Fixed assets | 125 349,96 | 69 939,36 | 14 528,76 | 0,00 | 90 675,23 | 71 914,91 | 53 154,59 | 34 393,94 |
| B. Current assets | 442 534,58 | 105 710,49 | 55 485,67 | 1 069 701,15 | 1 973 114,29 | 738 361,73 | 365 547,08 | 157 184,29 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | - | - | - | - |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | - | - | - | - |
| Total liabilities | 567 884,54 | 175 649,85 | 70 014,43 | 1 069 701,15 | 2 063 789,52 | 810 276,64 | 418 701,67 | 191 578,23 |
| A. Equity | 460 956,11 | 167 752,75 | 62 373,14 | 725 120,31 | 1 458 414,16 | 790 587,49 | 405 393,32 | 159 896,63 |
| B. Liabilities and provisions for liabilities | 106 928,43 | 7 897,10 | 7 641,29 | 344 580,84 | 605 375,36 | 19 689,15 | 13 308,35 | 31 681,60 |
| I. Long-term liabilities | - | - | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD